Related Experiment Video
Updated: May 15, 2026
10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Early onset neonatal group B streptococcal sepsis
1Department of Pediatrics, Alpert Medical School, Brown University, Providence, RI, USA. woh@wihri.org
American Journal of Perinatology
|January 17, 2013
Summary
Neonatal group B streptococcal (GBS) sepsis is a severe illness. Preventive strategies, including screening and intrapartum antibiotics, have significantly reduced GBS sepsis incidence in newborns.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Public Health
Background:
- Group B streptococcal (GBS) sepsis is a major cause of neonatal illness, leading to significant morbidity and mortality.
- GBS sepsis presents as early-onset (respiratory distress, cardiovascular complications) or late-onset (meningitis, neurodevelopmental impairment).
- Preventive strategies have been developed over three decades to combat GBS sepsis.
Purpose of the Study:
- To review the impact of preventive strategies on neonatal GBS sepsis.
- To highlight the reduction in GBS sepsis incidence due to screening and intrapartum antibiotic prophylaxis.
- To acknowledge the American Academy of Pediatrics' guidance for managing newborns with unknown GBS status.
Main Methods:
- Review of historical data on GBS sepsis incidence.
- Analysis of the effectiveness of universal maternal GBS screening.
- Evaluation of intrapartum antibiotic prophylaxis (IAP) impact.
Main Results:
- Significant reduction in GBS sepsis from 1.5 to 0.3 per 1,000 live births over 30 years.
- Demonstrated success of screening and IAP in disease prevention.
- Ongoing challenges include managing unknown maternal GBS status.
Conclusions:
- Preventive strategies have dramatically decreased neonatal GBS sepsis rates.
- Continued vigilance and adherence to guidelines are crucial for further reduction.
- Management algorithms are essential for newborns born to mothers with unknown GBS status.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...